Jens Gerth Selected Research

Irbesartan

10/2006

The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jens Gerth Research Topics

Disease

5	Proteinuria 01/2016 - 07/2008
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2016 - 07/2004
3	Renal Insufficiency (Renal Failure) 09/2008 - 10/2006
2	acquired Thrombotic thrombocytopenic purpura 01/2020 - 01/2020
2	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2016 - 08/2013
2	Chronic Renal Insufficiency 01/2010 - 07/2004
2	Atherosclerosis 01/2010 - 09/2008
2	Thrombocytopenia (Thrombopenia) 08/2008 - 09/2002
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 03/2024
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2024
1	Cardiac Tamponade 12/2022
1	Pericardial Effusion 12/2022
1	Aneurysm (Aneurysms) 05/2021
1	Acute Disease 01/2020
1	Disease Progression 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2010
1	Immune System Diseases (Immune Disorders) 11/2009
1	Brain Diseases (Brain Disorder) 11/2009
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 08/2009
1	Thrombotic Thrombocytopenic Purpura 02/2009
1	Delayed Graft Function 09/2008
1	Eosinophilia 08/2008
1	Body Weight (Weight, Body) 08/2008
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 08/2008
1	Rare Diseases (Rare Disease) 08/2008
1	Abscess 08/2008
1	Leukocytosis (Pleocytosis) 08/2008
1	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2008
1	Hypertension (High Blood Pressure) 10/2006
1	Type 2 Diabetes Mellitus (MODY) 10/2006
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2006
1	Anemia 09/2002

Drug/Important Bio-Agent (IBA)

2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2024 - 07/2008
2	caplacizumabIBA 01/2020 - 01/2020
2	AntibodiesIBA 01/2016 - 11/2009
2	CreatinineIBA 01/2012 - 07/2008
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2010 - 07/2008
2	Advanced Glycation End ProductsIBA 01/2010 - 10/2006
2	C-Reactive ProteinIBA 08/2008 - 07/2004
2	Prednisolone (Predate)FDA LinkGeneric 08/2008 - 07/2008
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2024
1	ThrombospondinsIBA 01/2016
1	AutoantibodiesIBA 01/2016
1	Rituximab (Mabthera)FDA Link 08/2013
1	Angiotensin Receptor AntagonistsIBA 09/2010
1	Sirolimus (Rapamycin)FDA Link 09/2010
1	Vitamin B 6IBA 01/2010
1	PyridoxamineIBA 01/2010
1	AntigensIBA 08/2009
1	thiamine triphosphorate (TTP)IBA 02/2009
1	CholesterolIBA 09/2008
1	Chlorambucil (Leukeran)FDA Link 07/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2008
1	Alkylating AgentsIBA 07/2008
1	Irbesartan FDA LinkGeneric 10/2006
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 10/2006
1	HomocysteineIBA 07/2004
1	EnzymesIBA 09/2002

Therapy/Procedure

5	Therapeutics 08/2013 - 07/2008
1	Pericardiectomy 12/2022
1	Stents 05/2021
1	Catheters 05/2021
1	Kidney Transplantation 01/2016
1	Laparotomy 08/2008
1	Retreatment 07/2008
1	Renal Dialysis (Hemodialysis) 07/2004